Information Document - Sale of Glucomed

Please find enclosed the Information Document in connection with the sale of Glucomed. The agreement was announced in a stock exchange notification on 14 August 2009.

The enclosed Information Document is issued in accordance with continuing obligations Chapter 3-5 in the regulations from Oslo Stock Exchange, which covers information requirement for corporate transactions exceeding 25 percent.

The document is also available at the www.navamedic.com.

For further information, please contact:

Bernt-Olav Røttingsnes, CFO/IRO Navamedic ASA


E-mail: bor [at] navamedic [dot] com


Mobile: +47 91 34 70 21